Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Abeona Therapeutics Inc
ABEOCurrent price
5.24 USD
-0.06 USD (-1.13%)
Last closed
5.30 USD
Company
www.abeonatherapeutics.com
ISIN
US00289Y1073
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
256 044 192 USD
Yield for 12 month
+1.95 %
1Y
3Y
5Y
10Y
15Y
ABEO
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio. Address: 6555 Carnegie Avenue, Cleveland, OH, United States, 44103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
16.75 USDP/E ratio
–Dividend Yield
–Current Year
+3 500 000 USD
Last Year
+1 414 000 USD
Current Quarter
–
Last Quarter
–
Current Year
+1 895 000 USD
Last Year
+964 000 USD
Current Quarter
–
Last Quarter
-1 667 000 USD
Key Figures ABEO
1 year
3 years
5 years
10 years
EBITDA
-54 747 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-37.81 %
PEG Ratio
–
Return On Equity TTM
-127.38 %
Wall Street Target Price
16.75 USD
Revenue TTM
–
Book Value
0.56 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
-28 001 000 USD
Earnings per share
-2.05 USD
Diluted Eps TTM
-2.05 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ABEO
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ABEO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:25
Payout Ratio
–
Last Split Date
05.07.2022
Dividend Date
–
Stock Valuation ABEO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
53.29
Price Sales TTM
61.63
Enterprise Value EBITDA
-0.58
Price Book MRQ
5.59
Financials ABEO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ABEO
For 52 weeks
3.05 USD
9.01 USD
50 Day MA
6.24 USD
Shares Short Prior Month
2 630 106
200 Day MA
5.72 USD
Short Ratio
10.79
Shares Short
2 576 845
Short Percent
6.29 %
BeatStart